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INTRODUCTION
The tumor suppressor PTEN (phosphatase and tensin homolog
deleted from chromosome 10; also known as MMAC1 or
TEP1) is a lipid phosphatase, which plays crucial roles in the
regulation of cellular proliferation, differentiation, apoptosis,
adhesion and migration (Cantley and Neel, 1999; Di Cristofano
and Pandolfi, 2000; Simpson and Parsons, 2001; Yamada and
Araki, 2001). Germline mutations of PTEN have been
identified in hereditary disorders, such as Cowden disease,
Lhermitte-Duclos disease and Bannayan-Zonna syndrome,
which are characterized by multiple benign tumors (mostly
hamartomas) and increased risk of cancers, such as breast and
thyroid malignancies (Liaw et al., 1997; Marsh et al., 1997;
Marsh et al., 1999; Nelen et al., 1997). Deletions and mutations
in the PTEN gene are also found at high frequency in many
sporadic human cancers, such as glioblastomas, endometrial,
prostate and breast cancers (Dahia, 2000). PTEN is one of the
most frequently mutated tumor suppressor genes in human
cancer, and the overall frequency of PTEN mutations in
sporadic human cancers is similar to that of the tumor
suppressor p53 (Stokoe, 2001).
PTEN contains a protein tyrosine phosphatase domain that
is similar to those of the dual-specificity phosphatases, which
dephosphorylate both phosphotyrosine and serine/threonine
residues (Li and Sun, 1997; Myers et al., 1997). In spite of the
homology with dual-specificity phosphatases, the in vitro
protein phosphatase activity of PTEN is not high, and PTEN
is very active on a highly acidic substrate. Both in vitro and
in vivo analyses indicate that the major substrate of PTEN
is the lipid phosphatidylinositol (3,4,5)-triphosphate
[PtdIns(3,4,5)P3], which is a direct product of PI3-kinase
(PI3K) (Maehama and Dixon, 1998; Myers et al., 1998;
Stambolic et al., 1998). This substrate specificity has been
confirmed by the crystal structure of PTEN (Lee et al., 1999).
Loss of PTEN function in embryonic stem (ES) cells and
human cancer cell lines results in PtdIns(3,4,5)P3
accumulation and the activation of its downstream signaling
molecule, Akt/PKB (Li and Sun, 1998; Li et al., 1998;
Ramaswamy et al., 1999; Sun et al., 1999; Wu et al., 1998).
Subsequently, activation of the PI3K/Akt pathway by the loss
of PTEN stimulates various biological functions, such as cell
cycle progression, cell survival and cell migration.
Several studies, including ours, have sought to elucidate the
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The tumor suppressor gene PTEN, which is frequently
mutated in human cancers, encodes a lipid phosphatase for
phosphatidylinositol 3,4,5-triphosphate [PtdIns(3,4,5)P3]
and antagonizes phosphatidylinositol 3 kinase. Primordial
germ cells (PGCs), which are the embryonic precursors of
gametes, are the source of testicular teratoma. To elucidate
the intracellular signaling mechanisms that underlie germ
cell differentiation and proliferation, we have generated
mice with a PGC-specific deletion of the Pten gene. Male
mice that lacked PTEN exhibited bilateral testicular
teratoma, which resulted from impaired mitotic arrest and
outgrowth of cells with immature characters. Experiments
with PTEN-null PGCs in culture revealed that these
cells had greater proliferative capacity and enhanced
pluripotent embryonic germ (EG) cell colony formation.
PTEN appears to be essential for germ cell differentiation
and an important factor in testicular germ cell tumor
formation.
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in vivo role of PTEN in development and tumorigenesis. PTEN
is crucial for normal development, as homozygous Pten-null
mice show overgrowth of cells and disorganized cell layers
in the cephalic and caudal regions, and die during early
embryogenesis at E6.5-9.5 (Di Cristofano et al., 1998;
Podsypanina et al., 1999; Suzuki et al., 1998). In addition, mice
that are heterozygous for the Pten-null mutation develop a
broad range of tumors. The Cre-LoxP conditional gene-
targeting system was adopted to analyze the in vivo function
of PTEN in development, differentiation and tumorigenesis
(Backman et al., 2001; Groszer et al., 2001; Kwon et al., 2001;
Li et al., 2002; Marino et al., 2002; Suzuki et al., 2001).
Somatic cell lineage-specific Pten-null mice have shown
distinct functions of PTEN in different organs. For example, T-
cell-specific deficiencies lead to defects in immunological
tolerance and subsequent autoimmune disease (Suzuki et al.,
2001). Nerve cell-specific loss leads to increased proliferation
and self-renewal of neural stem and/or progenitor cells
(Groszer et al., 2001).
Primordial germ cells (PGCs) are germ cell precursors that
emerge around E7.5 and exist transiently in embryos (Wylie,
1999). PGCs migrate into the genital ridges and eventually
differentiate into eggs and sperm. Although PGCs are
committed to the germ cell lineage, two lines of evidence
suggest that mammalian PGCs can de-differentiate into cells
that have broader developmental potential. First, PGCs can
give rise to testicular teratomas with various types of
differentiated cells when grafted to adult testis (Stevens, 1967;
Stevens, 1984). Second, pluripotent embryonic germ (EG)
cells can be established by culturing PGCs in vitro in the
presence of SCF (Stem cell factor), LIF (leukemia inhibitory
factor) and bFGF (basic fibroblast growth factor) (Matsui
et al., 1992; Resnick et al., 1992). However, it is likely
that unknown mechanisms operate to prevent PGC de-
differentiation, as testicular teratoma is rare in normal mice
(Stevens, 1967) and PGCs cannot be incorporated into normal
development even if injected into blastocysts (Labosky et al.,
1994a). In addition, clinical testicular teratomas are known to
develop from PGCs (Jiang and Nadeau, 2001; Looijenga and
Oosterhuis, 1999). 
In order to analyze the role of PTEN in germ cell
differentiation, we produced conditional Pten knockout mice
by crossing Ptenflox/flox females with Pten+/– males
that carried a single TNAP/Cre locus, in which Cre
was knocked into the PGC-specific TNAP (tissue-
non-specific alkaline phosphatase) gene (Lomeli et
al., 2000; Suzuki et al., 1998; Suzuki et al., 2001).
We discovered that deletion of the Pten gene in PGCs
caused testicular teratomas in all male newborn mice,
and that EG cell production was increased in both
sexes. These observations underscore the essential
role of PTEN in germ cell differentiation.
MATERIALS AND METHODS
Mice
To inactivate Pten in the PGCs, male Pten+/–:TNAP/Cre
mice were crossed with female Ptenflox/flox mice, as ectopic
recombination may be avoided when the TNAP/Cre locus
is transmitted from the male (Lomeli et al., 2000; Suzuki
et al., 1998; Suzuki et al., 2001). The morning on which a copulation
plug was found was defined as E0.5.
Histology, immunohistochemistry and the TUNEL assay
The testes, embryoid bodies and teratomas were fixed with 4%
paraformaldehyde and embedded in either methyl methacrylate or
OCT compound. The sections were stained with Hematoxylin and
Eosin using standard procedures. 
For immunohistochemistry, the sections were stained with the
following primary antibodies: anti-PTEN (1:50; Neomarkers, Fremont,
CA); anti-phosphorylated Akt (1:50; NEB, Beverly, MA); anti-mvh
(1:1000) (Toyooka et al., 2000); and the monoclonal antibodies TRA98
(1:500) (Tanaka et al., 1997) and 4C9 (1: 500) (Yoshinaga et al., 1991).
The Vectastain ABC kit (Vector Lab, Burlingame, CA) was used for
the detection of PTEN. Signals for mvh and TRA98 were visualized
using the appropriate Alexa-Fluor-conjugated secondary antibodies
(Molecular Probes, Eugene, OR). The 4C9 and phosphorylated Akt
proteins were detected using biotin-conjugated antibodies (Vector
Lab), followed by streptavidin-peroxidase or streptavidin-Texas Red
(Invitrogen, Carlsbad, CA).
For TNAP staining, whole embryos were fixed with 4%
paraformaldehyde and embedded in OCT compound. Serial
transverse sections were collected for every three sections, and stained
using the Alkaline Phosphatase Staining Kit (Sigma Diagnostics, St
Louis, MO). Ectopic PGCs were also stained for 4C9, as described
above. The TUNEL assay was carried out using the In Situ Cell Death
Detection Kit (Roche, Mannheim, Germany), according to the
manufacturer’s recommendations.
PGC culture
Genital ridges were obtained from E11.5 embryos and dissociated into
single cells by incubation with 0.05% trypsin, 0.02% EDTA in PBS.
Dispersed suspensions of PGC-containing tissues were cultured on
Sl/Sl4-m220 feeder cells in DMEM that was supplemented with 15%
fetal bovine serum, 2 mM glutamine, 1 mM sodium pyruvate and non-
essential amino acids, in the presence or absence of LIF and bFGF
(Koshimizu et al., 1996; Matsui et al., 1992). The feeder cells were
treated with 5 m g/ml mitomycin C for 2 hours and plated at 2 · 105
cells/well in 24-well plates 1 day before use. PGCs and EG cells were
fixed with 4% paraformaldehyde and visualized by alkaline
phosphatase staining, as described above. The number of adherent
PGCs 8 hours after seeding was defined as the number of seeded
PGCs. Multi-layered colonies that contained more than 20 cells were
counted as EG cell colonies, as described previously (Koshimizu et
al., 1996). The sex of the E11.5 embryos was determined using sex
chromosome-specific PCR (Chuma and Nakatsuji, 2001). 
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Fig. 1. Deletion of PTEN in PGCs. Immunohistochemical staining for PTEN
was carried out on E15.5 control (A, Ptenflox/–: TNAP/Cre–) and mutant (B,
Ptenflox/–: TNAP/Cre+) testes. In control mice, strong cytoplasmic staining was
observed in germ cells but the expression level was low in somatic cells. In
mutant mice, only background level of expression was observed both in germ
and somatic cells. Scale bar: 20 m m. 
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Analysis of EG cells
EG cells (5· 103 cells/ml) were plated as single cell suspensions in
DMEM medium that contained 1.0% methylcellulose to induce the
differentiation of embryoid bodies. At day 8 after induction, embryoid
bodies were collected and total RNA was extracted using the RNeasy
Mini Kit (Qiagen, Valencia, CA). One microgram of total RNA
was reverse-transcribed with the ThermoScript RT-PCR System
(Invitrogen). Semi-quantitative PCR was performed for 1 cycle at
95°C for 1 minute, followed by amplification cycles of 95°C for 30
seconds, 60°C for 30 seconds, 72°C for 40 seconds and, finally, 72°C
for 7 minutes in a PCR System 9700 (PE Applied Biosystems, Foster
City, CA). PCR amplification of the cDNA remained linear for 30
cycles (data not shown). The amplification cycles for each gene were
as follows: Wnt1, 27 cycles; collagen IV, 21 cycles; T, 24 cycles; and
b -actin, 17 cycles. The PCR products were analyzed by 2.0% agarose
gel electrophoresis, and visualized using ethidium bromide staining.
The following primer pairs were used for PCR amplification: Wnt1,
5¢ -GATTGCGAAGATGAACGCTGTTTC-3¢ and 5¢ -TCCTCCACG-
AACCTGTTGACGG-3¢ ; collagen IV, 5 ¢ -CAAGCATAGTGGTCC-
GAGTC-3¢ and 5¢ -AGGCAGGTCAAGTTCTAGCG-3¢ ; T, 5¢ -ATG-
CCAAAGAAAGAAACGAC-3 ¢ and 5¢ -AGAGGCTGTAGAACAT-
GATT-3¢ ; and b -actin, 5¢ -GTGACGAGGCCCAGAGCAAGAG-3¢
and 5¢ -AGGGGCCGGACTCATCGTACTC-3 ¢ . 
For teratoma induction, control and mutant EG cells (106 cells)
were suspended in PBS and subcutaneously injected into the flanks
of nude mice. After 2-4 weeks, the mice were sacrificed and the
tumors were processed for pathological analysis.
RESULTS
Conditional deletion of Pten in PGCs
To study the roles of PTEN in germ cell differentiation, and to
overcome the early embryonic lethality caused by conventional
knockout strategies, we generated a conditional Pten knockout
mouse by flanking exon 5, which encodes the phosphatase
domain of PTEN, with loxp sequences (Ptenflox) (Suzuki et al.,
2001). To avoid maternal expression of the Cre recombinase in
oocytes, Ptenflox/flox females were crossed with Pten+/– males
that carried a single TNAP/Cre locus, in which Cre was
knocked into the PGC-specific TNAP gene (Lomeli et al.,
2000). Analysis of TNAP/Cre mice that carried the reporter
transgene showed that the recombination efficiency was ~60%
at E13.5, and increased thereafter (Lomeli et al., 2000). Semi-
Fig. 2. (A) Hematoxylin and Eosin (HE)-stained sections of P0 testes. All Pten mutant mice developed bilateral teratomas with multiple foci
(n=9). ec, ectodermal vesicle; ed, endodermal vesicle; ud, undifferentiated cells. Scale bar: 20 m m. (B) Immunostaining with anti-phospho-Akt
antibody (top) showed hyper-phosphorylation of Akt in germ cells and early teratoma foci in E16.5 mutant mice. The same sections were
stained with propidium iodide (PI) (bottom) and the morphology of nuclei was examined by confocal microscopy at 0.8 m m optical sections
(arrowheads in a-c). Some of the hyper-phosphorylated cells had pyknotic nuclei (a) and mitotic figures (b,c). Scale bars: 10 m m. (C) Sections
of E14.5 testes were double-stained with anti-Mvh antibody and PI, and analyzed by confocal microscopy at 0.8 m m optical sections. Mitotic
figures were observed in Pten mutant PGCs (arrowheads). Scale bars: 5 m m. (D) The percentage of mitotic PGCs at E13.5, E14.5 and E16.5 in
control and mutant mice. The sections were stained with PI and anti-Mvh antibody. The percentage of mitotic cells in Mvh-positive cells
(mean±s.d.) was calculated and analyzed by Student’s t-test (P=0.48 at E13.5, *P<0.01 at E14.5 and †P<0.002 at E16.5). Three to six mice
were examined at each stage.
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quantitative genomic PCR analysis of purified PGCs showed
that Cre-mediated recombination at the Ptenflox locus occurred
with similar efficiency both in males and in females (data not
shown). Immunohistochemical analysis of E15.5 testes was
carried out to examine the efficiency of Cre-mediated deletion
of the floxed PTEN allele. The expression of PTEN was high
in germ cells but almost undetectable in somatic cells of the
control mice (Fig. 1A). By contrast, only background level of
expression was observed in the vast majority of germ cells in
the mutant mice (Fig. 1B), which demonstrates that Cre-
mediated deletion occurred very efficiently until E15.5.
Inevitable testicular teratoma formation in Pten-null
male newborn mice
Examination of the Pten mutant (Ptenflox/–:TNAP/Cre+) male
mice at the newborn stage (P0) revealed that bilateral testicular
teratomas with multiple foci had developed in all of the mutant
mice. The teratomas consisted of various differentiated and
undifferentiated cell types, and few germ cells were detected
in the mutant testes (Fig. 2A, Fig. 4B). These abnormal
phenotypes were not detected in the control (Ptenflox/–:
TNAP/Cre–; Ptenflox/+:TNAP/Cre+; Ptenflox/+:TNAP/Cre–)
mice. Immunostaining was carried out with specific antibody
against the active phosphorylated form of Akt, as Akt is a
critical downstream effector of PtdIns(3,4,5)P3 signaling
(Cantley, 2002; Vivanco and Sawyers, 2002). Hyper-
phosphorylation of Akt was detected in most gonadal PGCs
and early teratoma foci in the Pten mutant male mice at E16.5
(Fig. 2B), which suggests that PTEN loss induces Akt
activation. To know the status of the cells expressing hyper-
phosphorylation of Akt, propium iodide (PI) staining of the
nuclei was carried out. Pyknotic nuclei, typical features of
apoptotic cells (Fig. 2B, part a), and mitotic figures (Fig. 2B,
parts b,c) were observed in the significant proportion of the
cells. Meanwhile, unilateral teratoma formation was observed
occasionally in female Pten mutant mice a few weeks after
birth (data not shown). It has been believed that ovarian
teratomas originate from the parthenogenetically activated
oocytes (Colledge et al., 1994; Eppig et al., 1977; Hashimoto
et al., 1994). The mechanism of ovarian teratoma formation
is under investigation by crossing floxed-Pten mice and
oocyte-specific ZP3-Cre mice. 
During normal male germ cell development, PGCs enter
mitotic arrest at E13.5 and resume mitosis after birth
(Stevens, 1967; Wylie, 1999). The percentage of mitotic
PGCs in control mice was about 3% at E13.5; this percentage
gradually declined, and was undetectable after E15.5.
Although the percentage of mitotic PGCs in mutant mice at
E13.5 was similar, a significant proportion of the PGCs in
mutant mice exhibited mitotic figures between E14.5 and
E16.5 (Fig. 2C,D).
The apoptosis of germ cells was examined by the TUNEL
method (Fig. 3A). The percentages of apoptotic cells in mvh
(mouse vasa homologue)-positive germ cells were calculated
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Fig. 3. Apoptosis in Pten
mutant mice.
(A) Sections of embryo
testes from E13.5, E14.5
and E15.5 control and
mutant mice were
analyzed by the TUNEL
assay. Scale bars: 20 m m.
(B) The percentages of
apoptotic PGCs at E13.5,
E14.5 and E16.5. The
percentage of apoptotic
cells in Mvh-positive
germ lineage cells
(mean±s.d.) was
calculated and analyzed
using Student’s t-test
(P=0.22 at E13.5,
*P<0.01 at E14.5 and
†P<0.001 at E16.5).
Three to six mice were
examined at each stage.
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(Toyooka et al., 2000). As shown in Fig. 3B, no significant
differences were observed between the control and Pten-null
mice at E13.5. No apoptotic germ cells were observed in the
control male gonads after E14.5. However, a significant
percentage of the germ cells in the gonads of Pten-null mice
showed apoptosis after E14.5.
Fig. 4. Expression of the germ cell markers (Mvh and TRA98) and the immature cell marker (4C9) in the testes of control (A) and Pten mutant
(B) mice during embryogenesis. Sections of testes at E11.5, E16.5 and P0 were double-stained with TRA98 (green) and anti-Mvh (red)
antibodies. Adjacent or neighboring sections of the same samples were stained with 4C9 (brown) antibody. Similarly, sections of E13.5 gonads
were double-stained with anti-Mvh (green) and 4C9 (red) antibodies, and adjacent sections were stained with TRA98 (green) antibody. At
E13.5, all 4C9-positive PGCs expressed the germ-lineage-specific marker Mvh. In E16.5 mutant gonads, TRA98-positive teratoma cells, which
were Mvh negative or weakly positive for Mvh (arrowheads), and outgrowth of these cells (arrow) were observed. In P0, large teratomas that
were Mvh negative, weakly positive for TRA98 and 4C9 positive were observed. Scale bars: 50 m m. At each developmental stage, at least three
mice were examined and essentially similar results were obtained.
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Expression of pluripotent cell and germ cell markers
in Pten-null testes
To determine the profile of PGC development in control and
mutant mice, we examined the expression patterns of germ
cell and pluripotent cell markers (Fig. 4). The germ-lineage-
specific marker mvh is expressed in post-migratory PGCs in
gonads (Toyooka et al., 2000). The other germ cell marker,
a nuclear antigen recognized by the TRA98 monoclonal
antibody, is expressed in gonadal PGCs and EG cells (Tanaka
et al., 1997). The 4C9 monoclonal antibody, which reacts with
carbohydrate groups on the surfaces of pluripotent cells from
two-cell embryos to epiblast cells and in immature PGCs, was
used as a stem cell marker (Yoshinaga et al., 1991).
PGCs in control mice began to express mvh and TRA98 at
E11.5, and expression was sustained until birth (Fig. 4A). By
contrast, expression of the pluripotent cell marker 4C9 was
undetectable by E16.5. Similarly, all of the 4C9-positive PGCs
in the Pten mutant embryos were mvh-positive at E13.5, which
indicates that the PGCs in the mutant mice acquired the
characteristics of germ lineage cells (Fig. 4B). TRA98
expression was also activated in the PGCs of the mutants.
Taken together, the results show that all immature PGCs
differentiated into relatively mature PGCs, even in the PTEN-
null condition (Fig. 4B). However, at around E16.5, TRA98-
positive cells, which were either mvh-negative or weakly
positive for mvh, emerged (Fig. 4B, arrowheads) and
outgrowth of these cells was observed (Fig. 4B, arrow). Finally,
large teratomas were observed at P0. Those teratomas
consisted of the cells with the marker expression similar to EG
cells, namely, mvh-negative, weakly positive for TRA98
and 4C9-positive. PTEN null teratomas would emerge by
proliferation of relatively immature PGCs or de-differentiation
from germ cells. In either case, loss of PTEN caused significant
effects on the differentiation state of germ lineage cells. 
Increased numbers of ectopic PGCs in the Pten-null
mice
PGCs first appear as a TNAP-positive population posterior to
the primitive streak at the gastrula stage (E7.5), in the base of
the allantoic diverticulum (Gomperts et al., 1994; Wylie, 1999).
The cells become incorporated into the developing hindgut and
then migrate out of the hindgut into the surrounding connective
tissue at E9.5. The PGCs leave the gut endoderm and
transverse the dorsal mesentery toward the coelomic angles.
Finally, the first PGCs reach the genital ridges through the
mesonephros region by E11.0-11.5. The vast majority of PGCs
colonize the gonad primordia by E13.
PGC distribution at E12.5 was examined by TNAP staining
(Fig. 5). The number of PGCs in the genital ridges of normal
mice was comparable with that of Pten-null mice. By contrast,
the numbers of ectopic PGCs that were localized outside
the genital ridges in control and Pten-null mice differed
significantly. The ectopic PGCs were positioned mainly along
the path of PGC migration. However, low numbers of ectopic
PGCs were detected in an irrelevant region (designated as
‘out of route’ in Fig. 5A,C). Thereafter, the ectopic PGCs
disappeared in both the control and Pten-null mice by E15.5.
Although the cell adhesion activities of the Pten-null PGCs
were extensively examined, they were not significantly
different from those of control PGCs (data not shown). In
addition, the percentage of PGCs with motile morphology in
vitro was not increased (data not shown). These observations
imply that the increased numbers of ectopic PGCs could be
caused by the increased survival rather than the altered
migratory capacity, but further analysis is necessary to
discriminate these two possibilities.
EG cell formation in PGC-specific Pten-null mice
We also tested whether the Pten deletion affected the
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Fig. 5. Extra-gonadal PGCs in Pten mutant mice. (A) Route of PGC
migration. Transverse section of E12.5 embryos stained for alkaline
phosphatase activity. Alkaline phosphatase-positive cells were
stained red. The normal migration pathway is indicated by arrows.
PGCs become incorporated into the wall of the developing hindgut
(gut; E8.5), migrate actively into the dorsal mesentery (dm; E9.5)
and then to the genital ridges (E10.5-12.5). The path of ‘out of route’
PGCs is shown by a broken arrow. dm, dorsal mesentery; cw,
coelomic wall; gnd, gonad; mes, mesonephros. (B) The percentage
and the number of extra-gonadal PGCs at E12.5. The serial
transverse sections of whole embryos were stained with alkaline
phosphatase substrate as described in A. The number of PGCs in
three sections was counted in every case. Ectopic PGCs were also
stained with 4C9 antibody for confirmation. The results were
analyzed by Student’s t-test (*P<0.0025, †P<0.01). (C) The
distribution of PGCs at E12.5. The values for individual mice are
plotted (Student’s t-test; *P<0.05, †P<0.01, and ‡P<0.005).
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proliferative capacity and EG cell-forming efficiency of PGCs
in vitro. SCF, LIF and bFGF act as survival and growth factors
for PGCs in vitro, and EG cells can be formed when all these
growth factors are added to PGC cultures (Dolci et al., 1991;
Godin et al., 1991; Matsui et al., 1992; Matsui et al., 1990;
Resnick et al., 1992). When E11.5 gonadal PGCs from control
embryos were cultured on feeder cells that expressed the
membrane-bound form of SCF, most of the E11.5 PGCs
rapidly underwent apoptosis, as previously reported (Fig. 6A)
(Koshimizu et al., 1996; Matsui et al., 1992). By contrast, PGC
numbers increased when cells from mutant mice were used. In
the presence of LIF alone, or LIF and bFGF, significantly more
mutant PGCs than controls were observed after three days of
culture (Fig. 6A). Significant differences were observed in
PGCs from both male and female mice.
The efficiency of EG cell colony formation was remarkably
high (48.2±11.5%, mean±s.e.m.) when the E11.5 PTEN-
mutant PGCs were cultured (Fig. 6B). EG colonies were
defined by TNAP staining (Fig. 6C) and immunostaining with
anti-SSEA-1 antibody (data not shown). The EG cell-cloning
efficiency was significantly higher (P<0.01; Student’s t-test) in
mutant PGCs than in control PGCs (1.5±0.6%). Once again,
significant differences were observed regardless of mouse
gender. EG cells that were established from mutant PGCs had
a degree of normal differentiation capacity, as revealed by in
vitro embryoid body formation and in vivo teratoma formation.
Embryoid body formation occurred at the same frequency in
mutant EG cells and in controls (data not shown), and RT-PCR
analysis revealed that the mutant embryoid bodies consisted of
three germ layers (Fig. 7A,B). Both Pten mutant and control
Fig. 6. In vitro culture of PGCs from Pten mutant mice.
(A) Increased proliferation of E11.5 PGCs from Pten mutant mice.
Cell suspensions of E11.5 gonads were seeded on Sl/Sl4-m220 feeder
cells that expressed the membrane-bound form of SCF, and cultured
in the presence or absence of LIF and bFGF. Changes in PGC
number (%) were calculated by dividing the number of PGCs at day
3 by the number of seeded PGCs. Data are mean±s.d. (*P<0.005,
†P<0.05). (B) EG cell colonies formed in the presence of LIF and
bFGF at day 6 after seeding. EG cells were visualized by alkaline
phosphatase staining. (C) Increased EG cell production in E11.5
PGCs from Pten mutant mice. Multi-layered colonies that contained
more than 20 cells were counted as EG cell colonies, as described
previously (Koshimizu et al., 1996). The EG colony-forming
efficiency (%) was calculated by dividing the number of EG cell
colonies at day 6 by the number of seeded PGCs. The values for
individual mice are plotted (P<0.01). 
Fig. 7. Differentiation capacity of Pten mutant-derived EG cells.
(A) Embryoid bodies with various cell types formed when
differentiation was induced in methylcellulose cultures for 8 days.
Scale bars: 50 m m. (B) RNA from embryoid bodies was subjected to
semi-quantitative RT-PCR analysis to examine the expression of
ectodermal (Wnt1), endodermal (collagen IV) and mesodermal (T)
markers. b -Actin was used as a loading control. Expression of all
three markers was induced both in control and in mutant EG cell-
derived embryoid bodies. (C) Teratomas with differentiated cells that
formed when EG cells were transplanted into nude mice. Scale
bars:50 m m.
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EG cells produced teratomas after transplantation into nude
mice (Fig. 7C).
DISCUSSION
In this study, we demonstrate that PTEN is critical for the
correct differentiation of PGCs to mature germ cells. Increased
mitotic levels, higher percentages of apoptotic cells, and
teratoma formation were observed in vivo for mutant male
gonads (Figs 2-4). Moreover, in vitro experiments showed that
the proliferative activities of PGCs and the efficiency of EG
cell colony formation were enhanced by the loss of PEN
function (Figs 6, 7). 
Our observations indicate deregulated maintenance of PGCs
in Pten-null male mice. Two main abnormalities were detected
in Pten-null male gonads after E14.5, i.e. increased numbers
of mitotic figures and higher apoptotic ratios (Figs 2, 3). One
of the important roles of PTEN is to induce G1 arrest through
the suppression of the PI3K/Akt pathway (Li and Sun, 1998;
Ramaswamy et al., 1999; Sun et al., 1999). It seems reasonable
that a significantly higher proportion of the Pten-null germ
cells show mitotic figures. Although PTEN is known to cause
apoptosis in many cell types (Li et al., 1998; Myers et al., 1998;
Stambolic et al., 1998; Sun et al., 1999), loss of PTEN induced
apoptosis of germ cells. This phenomenon seems ostensibly
paradoxical, but might be explained as follows. Isolated
activation of the PI3K/Akt pathway without concomitant
activation of the other pathways may be perceived as abnormal
by the cells and thereby trigger apoptosis. The mechanism by
which some proportion of PTEN null germ cells escaped
apoptosis and continued to grow remains unknown at present.
Meanwhile, it seems unlikely that additional genetic alteration
took place for teratoma formation, because the onset of
teratoma was quite early. Selection by local environmental
factors or epigenetic events of germ lineage cells might be
involved in the survival and subsequent teratoma formation.
Overall, significant numbers of male germ cells die by
apoptosis; some cells survive and keep growing, and
eventually, teratoma develops from the surviving cells in the
Pten-null mice. These phenotypes are similar to those of
129/Sv-ter mutant mice, in which both testicular teratoma and
germ cell loss occur (Noguchi et al., 1996; Noguchi and
Stevens, 1982; Stevens, 1984). PGC mitotic activity correlates
strongly with the incidence of teratomas in 129/Sv-ter mice
(Noguchi and Stevens, 1982). Pten mutant mice show impaired
mitotic arrest, as do 129/Sv-ter mice, which suggests that
mitotic quiescence is the critical event in the establishment of
male germ cell commitment. The Pten and ter loci are on
chromosomes 19 and 18, respectively (Asada et al., 1994;
Hansen and Justice, 1998; Sakurai et al., 1994); however,
common molecular mechanisms for teratoma formation and
loss of germ cells may exist. 
The in vitro survival and proliferation properties of PGCs
were enhanced by the Pten-null mutation, which resembles
testicular teratoma formation, and EG cell colony formation
was also increased significantly (Figs 6, 7). The potential of
EG cell formation of normal mice is very high in migratory
phase PGCs at E8.5, then declined gradually, and eventually
disappeared in E13.5 gonadal PGCs (Labosky et al., 1994a;
Labosky et al., 1994b; Matsui et al., 1992). The high level of
EG cell formation in the E11.5 Pten mutants resembles that of
immature PGCs, and may be attributed partly to the high
proliferative activities of PGCs. However, it is unlikely that the
abnormalities are caused simply by increased proliferation, as
cells that are derived from PTEN-null PGCs attain much
broader differentiation potential as teratomas or EG cells. It is
reasonable to assume that PTEN loss induces the de-
differentiation of germ lineage-committed cells or sustains the
immature state of PGCs longer than in control mice. 
Two lines of evidence support this hypothesis. The first
comes from the study of cell lines, in which PI3K signaling is
involved in de-differentiation (Kobayashi et al., 1999; Singh et
al., 2002). The second is derived from tissue-specific PTEN-
deficient mice. PTEN-deficient neural stem cells exhibit
increased proliferation and self-renewal capacities (Groszer
et al., 2001). In addition, B-cell-specific PTEN-null mice
have significantly increased numbers of B1 B cells, i.e. a
subpopulation of B cells that resides mainly in the pleural and
peritoneal cavities, and possess self-renewing activities
(Suzuki et al., 2003). Taken together with our present data, the
tumor suppressor PTEN negatively regulates self-renewal and
proliferation in various stem cell systems. In addition to self-
renewal and proliferation, our results suggest that PTEN is
involved in the normal differentiation of PGCs. Mutant PTEN
is frequently involved in tumor proliferation, and may enable
tumor cells to regain pluripotency (Cantley and Neel, 1999; Di
Cristofano and Pandolfi, 2000; Simpson and Parsons, 2001;
Yamada and Araki, 2001). Tumors often originate through the
transformation of stem cells, and it has been hypothesized that
the physiological and pathological properties of stem cells are
regulated by the same signaling pathway (Penninger and
Woodgett, 2001; Reya et al., 2001). It seems likely that PTEN
negatively regulates not only self-renewal and proliferation, but
also the maintenance of immaturity of both tumor cells and
stem cells.
The receptors for various growth factors that activate the
PI3K signaling pathway, e.g. SCF, LIF and bFGF, are
expressed in gonadal PGCs (Cheng et al., 1994; Pesce et al.,
1997; Resnick et al., 1998). As Akt was hyper-activated in Pten
mutant PGCs, it is likely that the loss of PTEN enhanced the
PI3K signaling pathway, which then resulted in the deregulated
differentiation of PGCs. Although EG cell formation was
enhanced by the null mutation of Pten, no EG cell formation
was observed without the addition of LIF or bFGF.
Accordingly, the loss of PTEN function itself is not sufficient
for enhanced EG colony formation, but probably increases the
signals for PI3K, which is one of the downstream molecules
for signaling via SCF, LIF and bFGF. 
In conclusion, PTEN (PI3K) signaling plays a critical role
in germ cell differentiation. Teratoma formation and increased
EG colony formation suggest that PtdIns(3,4,5)P3 signaling is
involved in the maintenance of stem cell characteristics.
Further analysis of PtdIns(3,4,5)P3 signaling may provide new
insights into stem cell biology.
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